CDK4 and renal cell carcinoma: Similarly, significantly elevated levels of p-RB, CDK4, and Cyclin D1 were also observed in OS-RC-2/SR and TK-10/SR cells (Supplementary Figures 4A–D), indicating that CDK4-RB pathway was reactivated in sunitinib resistant RCC cells.